Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3763 3783
This examiner grants 68% of resolved cases
Quynh-Nhu Hoang Vu works in Tech Center 3700 and Art Unit 3763. The examiner has 998 resolved cases. The allowance rate is 68.5 percent. This figure indicates a moderate likelihood of success for applicants. Practitioners should prepare for a standard prosecution process when working with this examiner in Art Unit 3763.
The interview lift is 27.4 percent. This suggests that interviews can be a helpful way to improve the 68.5 percent allowance rate. Practitioners should evaluate the potential for direct communication to address examiner concerns and resolve rejections. The positive lift indicates that the examiner is generally responsive to verbal arguments in Tech Center 3700.
The median days to allowance is 1283. This timeline provides a benchmark for the expected duration of the prosecution process for successful applications. With 998 resolved cases, the examiner has a significant track record in Art Unit 3763. This volume of data offers a reliable basis for understanding the examiner's performance and typical timelines for patent issuance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17970705 | SYSTEMS AND METHODS FOR PRODUCING MIXTURES | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18048571 | SYSTEMS AND METHODS FOR PRODUCING MIXTURES | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18215420 | INFUSION PUMP AND SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLLE MEDICAMENTS | Non-Final OA | Trustees of Boston University |
| 18282933 | SURGICAL DRAIN FOR COLLECTION AND PRESERVATION OF TUMOR-ASSOCIATED BIOMARKERS IN SURGICAL DRAIN FLUID | Non-Final OA | Washington University |
| 18701321 | MICRONEEDLE INJECTOR AND METHODS OF MAKING AND USING SAME | Non-Final OA | Merck Sharp & Dohme LLC |
| 18441964 | CONTROLLING MEDICATION DELIVERY SYSTEM OPERATION AND FEATURES BASED ON AUTOMATICALLY DETECTED MUSCULAR MOVEMENTS | Final Rejection | Medtronic MiniMed, Inc. |
| 18608084 | MULTI-STAGE CONNECTOR DISLODGEMENT PREVENTION DEVICE | Non-Final OA | CareFusion 303, Inc. |
| 18597192 | DUAL MODE GEOFENCING FOR MEDICAL DEVICES | Non-Final OA | CareFusion 303, Inc. |
| 18699271 | ACCESS DEVICE | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18119197 | TIP-LOADED MICRONEEDLE ARRAYS FOR TRANSDERMAL INSERTION | Non-Final OA | Carnegie Mellon University |
| 18627689 | DISINFECTION CAP | Non-Final OA | Becton, Dickinson and Company |
| 18039019 | ARRANGEMENT FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE | Non-Final OA | Sanofi |
| 17945632 | Device and Method for Determining Information Related to a Medical Device | Non-Final OA | Sanofi-Aventis Deutschland GmbH |
| 17412684 | SYSTEMS AND METHODS FOR ACTIVATING DRUG DELIVERY DEVICES | Final Rejection | Insulet Corporation |
| 18218974 | EXTENDABLE LUMEN CATHETER DEVICE | Final Rejection | SCIENTIA VASCULAR, INC. |
| 18535032 | Infusion Pump Apparatus, Method and System | Final Rejection | DEKA Products Limited Partnership |
| 17035536 | Devices, Methods and Systems for Wireless Control of Medical Devices | Non-Final OA | DEKA Products Limited Partnership |
| 18706954 | Rotator for a medicament delivery device | Non-Final OA | SHL Medical AG |
| 17398221 | INTEGRATED CLOSED-LOOP MEDICATION DELIVERY WITH ERROR MODEL AND SAFETY CHECK | Final Rejection | Cambridge Enterprise Limited |
| 17763600 | MEASURING PARAMETERS ASSOCIATED WITH DRUG ADMINISTRATION AND DRUG ADMINISTRATION DEVICES INCORPORATING SAME | Non-Final OA | JANSSEN PHARMACEUTICALS, INC. |
| 18703368 | CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM | Non-Final OA | MEDTRUM TECHNOLOGIES INC. |
| 16804707 | VARIABLE CURRENT DENSITY SINGLE NEEDLE ELECTROPORATION SYSTEM AND METHOD | Final Rejection | Inovio Pharmaceuticals, Inc. |
| 18622067 | METHODS FOR BETTER DELIVERY OF ACTIVE AGENTS TO TUMORS | Final Rejection | SOFUSA HOLDINGS LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy